Rößner, P. M. (2019). Characterization of T-cells in Chronic lymphocytic leukemia and their modulation by clinically-approved targeted therapies with PI3Kdelta inhibitors.
Chicago-Zitierstil (17. Ausg.)Rößner, Philipp M. Characterization of T-cells in Chronic Lymphocytic Leukemia and Their Modulation by Clinically-approved Targeted Therapies with PI3Kdelta Inhibitors. Heidelberg, 2019.
MLA-Zitierstil (9. Ausg.)Rößner, Philipp M. Characterization of T-cells in Chronic Lymphocytic Leukemia and Their Modulation by Clinically-approved Targeted Therapies with PI3Kdelta Inhibitors. 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.